Oncology and Hematology

The Hemato-Oncology Business Unit provide scientific, medical, regulatory and operational expertise and tailored solutions ensuring successful execution for complex oncology trials.


TFS dedicated oncology team members understand very well the latest challenges around oncology trials these days- from complex early phase trials including basket trials, precision medicines and immuno-oncology. Utilizing the TFS Oncology team for your trials yield the following benefits:

  • Rigorous oversight from study start to end with guaranteed optimal quality execution
  • Assigned study team members leverage experience from previous relevant trials ensuring a smooth seamless execution
  • Consult with TFS’s true expert Key Opinion Leaders and medical advisors as early as possible within your drug development process which ensures a robust clinical trial design resulting in limited or no feedback from regulatory bodies
  • Using quality experienced sites with expedited start up timelines and a timely completion of subject recruitment 
  • Our approved oncology vendors have ample experience conducting complex analyses successfully

Added Value of the Hemato-Oncology Business Unit

  • Global, international and regional experience in oncology
  • In-depth therapeutic, scientific & strategic knowledge
  • Operational delivery excellence through proactive planning, risk mitigation & standardized processes 
  • Access to our global KOL and site network
  • Partnership minded approach and customer centric focus
  • TFS’ most senior personnel, including our Oncology Leadership team commitment and Executive oversight